| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0072 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |